← Browse by Condition
Medical Condition
intracerebral hemorrhage
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for intracerebral hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — intracerebral hemorrhage Clinical Trials
How many clinical trials are currently recruiting for intracerebral hemorrhage?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for intracerebral hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for intracerebral hemorrhage?
intracerebral hemorrhage research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a intracerebral hemorrhage clinical trial?
Eligibility criteria for intracerebral hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 2
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05089331
Recruiting
ROSE-Longitudinal Assessment With Neuroimaging
Enrollment
250 pts
Location
United States
Sponsor
State University of New York a...
NCT07246473
Recruiting
Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage
Enrollment
86 pts
Location
China
Sponsor
Beijing Tiantan Hospital
NCT07410624
Recruiting
Augmented Renal Clearance in Neurocritical Care
Enrollment
512 pts
Location
United States, Canad...
Sponsor
University of Alberta
NCT05434065 Phase 2
Recruiting
Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage
Enrollment
60 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT06918964
Recruiting
TaVNS for Acute Intracerebral Hemorrhage
Enrollment
186 pts
Location
China
Sponsor
Beijing Tiantan Hospital
NCT06091332 Phase 2
Recruiting
Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial
Enrollment
75 pts
Location
China
Sponsor
Huashan Hospital
NCT05460793
Recruiting
Dutch Intracerebral Hemorrhage Surgery Trial
Enrollment
600 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
NCT07187687
Recruiting
TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
Enrollment
750 pts
Location
China
Sponsor
Xuanwu Hospital, Beijing
NCT07458880
Recruiting
Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control
Enrollment
140 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology